People: Cynosure Inc (CYNO.OQ)

CYNO.OQ on NASDAQ Stock Exchange Global Select Market

24.77USD
17 Apr 2014
Price Change (% chg)

$0.27 (+1.10%)
Prev Close
$24.50
Open
$24.50
Day's High
$25.03
Day's Low
$24.40
Volume
58,951
Avg. Vol
92,133
52-wk High
$31.48
52-wk Low
$21.14

Search Stocks

Summary

Name Age Since Current Position

Michael Davin

55 2013 Chairman of the Board, Chief Executive Officer

Timothy Baker

52 2013 Chief Financial Officer, Chief Operating Officer, Executive Vice President, Treasurer

Douglas Delaney

46 2005 Executive Vice President - Sales

Andrea Cangioli

48 2002 Director

William Flannery

67 2013 Director

Brian Barefoot

70 2011 Independent Director

Ettore Biagioni

54 2005 Independent Director

Marina Hatsopoulos

47 2008 Independent Director

Thomas Robinson

54 2005 Independent Director

Biographies

Name Description

Michael Davin

Mr. Michael R. Davin is Chairman of the Board, Chief Executive Officer of Cynosure Inc. He served as President of the Company. Mr. Davin has been resident and chief executive officer and a director since September 2003, and became the chairman of boad of directors in October 2004. Mr. Davin has over 25 years of experience in the light-based technology field. From 1998 to 2003, Mr. Davin served as co-founder and vice president of worldwide sales and strategic development of Cutera, Inc., a provider of laser and other light-based aesthetic treatment systems. Prior to co-founding Cutera, Mr. Davin spent 11 years at Coherent Medical, a manufacturer of laser, optics and related equipment, in senior management positions in sales, marketing and clinical development.

Timothy Baker

Mr. Timothy W. Baker is Chief Financial Officer, Chief Operating Officer, Executive Vice President, Treasurer of Cynosure Inc. He is Chief Operating Officer of the Company since June 24, 2013. Mr. Baker has been the executive vice president, chief financial officer and treasurer since March 2004. From July 2003 to February 2004, Mr. Baker served as vice president, finance of Stryker Biotech, a division of Stryker Corporation, a medical products and services provider. From July 2000 to June 2003, Mr. Baker served as president and chief financial officer of Photoelectron Corp., a provider of miniature x-ray systems for radiation therapy. From January 1996 to July 2000, Mr. Baker served as the chief financial officer and vice president of operations of Radionics, Inc., a provider of surgical devices. Mr. Baker is a certified public accountant and holds an M.B.A. in operations management.

Douglas Delaney

Mr. Douglas J. Delaney is Executive Vice President - Sales of Cynosure Inc. Mr. Delaney has been executive vice president, sales since February 2005 and has worked in medical laser sales for more than 16 years. From May 2004 until February 2005, Mr. Delaney was vice president, North American sales, and from September 2003 until May 2004, he was director of North American sales. From September 1999 to September 2003, Mr. Delaney served as national sales manager of Cutera.

Andrea Cangioli

Mr. Andrea Cangioli is Director of Cynosure Inc. Mr. Cangioli has been a director since 2002. Mr. Cangioli has served as a director and the general manager of El.En. since 1992. Mr. Cangioli also serves on the boards of other El.En. affiliated companies.

William Flannery

Brian Barefoot

Mr. Brian M. Barefoot is the Independent Director of Cynosure Inc., since 2011. From 2001 to 2008, Mr. Barefoot served as Babson College president. From 1996 to 2001, Mr. Barefoot served as chairman of the board of trustees of Babson College. Mr. Barefoot serves on the boards of directors of Blue Cross Blue Shield of Massachusetts, where he is Chair of the Finance and Business Performance Committee and a member of the audit committee. Mr. Barefoot serves as a director of Array Health Solutions, Inc., a health care technology and services company, and of Big Belly Solar, a renewable energy-focused waste collection company, and he is a senior advisor to Carl Marks Advisory Group LLC, a New York-based middle market merchant bank.

Ettore Biagioni

Mr. Ettore V. Biagioni is the Independent Director of Cynosure Inc. He has been a director since 2005. Since 2004, Mr. Biagioni has been a managing partner of Alothon Group LLC, a private equity firm which he co-founded. From 1998 to 2004, Mr. Biagioni served as head of the Latin America Private Equity Group of Deutsche Bank/Bankers Trust Company. Mr. Biagioni serves on the boards of directors of several private companies.

Marina Hatsopoulos

Ms. Marina Hatsopoulos is Independent Director of Cynosure Inc., since November 2008. Hatsopoulos has been a private investor since 2007. From August 2005 to September 2007, she was a director of Contex Holdings, a leading manufacturer of large-format scanners. From December 1994 to August 2005, she served as chief executive officer and director of Z Corporation, a leader in the 3D printing market, which was sold to Contex Scanning Technology in 2005. From 2005 through 2010, Ms. Hatsopoulos served as a director of the GSI Group Inc., a supplier of precision technology to the global medical, electronics and industrial markets and semiconductor systems. From 2007 until its sale to Sara Lee in 2011, Ms. Hatsopoulos was a director of Tea Forte, a supplier of luxury tea products. Since 2012, she has served as the chairperson of the board of directors of Levitronix Technologies, the worldwide leader in magnetically levitated bearingless motor technology, and as a director of Dear Kate, a women’s apparel company. Ms. Hatsopoulos has experience serving as a director and advisor for both public and private companies, which enhances her contributions to the board of directors.

Thomas Robinson

Mr. Thomas H. Robinson is Independent Director of Cynosure Inc., since 2005. Since September 2011, Mr. Robinson has served as a partner with RobinsonButler, an executive search firm. During 2010, Mr. Robinson served as managing director at Russell Reynolds Associates. From 1998 to 2010, Mr. Robinson served as managing partner of the North American medical technology practice, which includes the medical device, hospital supply/distribution and medical software areas, of Spencer Stuart, Inc., a global executive search firm. From 2002 to 2010, Mr. Robinson had been a member of Spencer Stuart’s board services practice, which assists corporations to identify and recruit outside directors. From 1998 to 2000, Mr. Robinson headed Spencer Stuart’s North American biotechnology specialty practice. From 1993 to 1997, Mr. Robinson served as president of the emerging markets business at Boston Scientific Corporation, a global medical devices manufacturer. From 1991 to 1993, Mr. Robinson served as president and chief operating officer of Brunswick Biomedical, a cardiology medical device company. In 2009, Mr. Robinson became a director of SANUWAVE Health, a publicly-traded regenerative medicine company.

Basic Compensation

Name Fiscal Year Total

Michael Davin

2,254,520

Timothy Baker

1,294,920

Douglas Delaney

1,024,130

Andrea Cangioli

--

William Flannery

--

Brian Barefoot

--

Ettore Biagioni

--

Marina Hatsopoulos

--

Thomas Robinson

--
As Of 30 Dec 2012

Options Compensation

Name Options Value

Michael Davin

642,336 11,291,600

Timothy Baker

343,681 6,024,005

Douglas Delaney

360,943 6,333,520

Andrea Cangioli

0 0

William Flannery

0 0

Brian Barefoot

0 0

Ettore Biagioni

0 0

Marina Hatsopoulos

0 0

Thomas Robinson

0 0
Search Stocks